JSHealth Vitamins Pty Ltd fined $26,640 for alleged unlawful advertising

The Therapeutic Goods Administration has issued two infringement notices totalling $26,640 to JSHealth Vitamins Pty Ltd for alleged unlawful use of restricted and prohibited representations in advertising of complementary medicines.

It is alleged that the company’s advertising included references and implied claims relating to serious health conditions including cancer and Alzheimer’s disease. These are restricted and prohibited representations that are not permitted to be used in advertising without permission from the TGA, which the company did not have.

Advertisers of therapeutic goods must not use claims and indications in advertising that breach the requirements of the Therapeutic Goods Act 1989 and the Advertising Code - external site.

Consumer information

Listed complementary medicines are lower risk therapeutic goods that are included in the Australian Register of Therapeutic Goods (ARTG) without undergoing TGA assessment of the evidence to support the product’s indications (or therapeutic uses). These medicines can only use pre-approved permitted indications and only contain certain low-risk permissible ingredients.

The TGA encourages the reporting of suspected non-compliant advertising.

Contact for members of the media:

• Email: news@health.gov.au
• Phone: 02 6289 7400